Pregnancy undergoing for elective Cesarean delivery under spinal anesthesia oxytocin, oxytocin bolus, oxytocin infusion, uterine atony postpartum hemorrhage, Cesarean section, Cesarean delivery
Conditions
Interventions
LRS 1,000 ml + oxytocin 20 IU drip 125 ml/h,Oxytocin bolus 5 IU
Active Comparator Drug,Active Comparator Drug
Low-rate oxytocin infusion 2.5 U/h,Oxytocin bolus 5 IU
Sponsors
Khon Kaen University
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Pregnancy aged 18-40 years old, GA 37-42 weeks, ASA ll, singleton, scheduled undergoing elective Cesarean delivery under spinal anesthesia
Exclusion criteria
Exclusion criteria: Previous uterine surgery other than cesarean section, high risk of uterine atony (macrosomia, chorioamnionitis, polyhydramnios, uterine mass), high risk of postpartum hemorrhage (placenta previa or other placenta disorders, history of postpartum hemorrhage, coagulopathy, thrombocytopenia, pre-eclampsia)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adequate uterine contraction at 3 minutes after fetal delivery percentage | — |
Secondary
| Measure | Time frame |
|---|---|
| Uterine tone at 3 minutes after fetal delivery percentage,Additional uterotonic agents after fetal delivery percentage,Estimate blood loss more than 500 ml after fetal delivery percentage,Mild adverse effects (nausea/vomiting, flushing, tachycardia) after fetal delivery until end of operation percentage,Severe adverse effects (hypotension, chest pain, EKG change) after fetal delivery until end of operation percentage | — |
Countries
Thailand
Contacts
Public Contactwichuda pongsri
ANESKKU
Outcome results
None listed